Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-01

Clinical Trial Update: Study to Evaluate the Clinical Value and Safety of Xiyanping Injection in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease(COPD) Based on Real-world Clinical Data

View source ↗

Summary

This clinical trial protocol evaluates the clinical value and safety of Xiyanping Injection for treating acute exacerbations of chronic obstructive pulmonary di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Xiyanping Injection (Xiyanping)

Snippet

Sponsor: Jiangxi Qingfeng Pharmaceutical Co. Ltd. | Conditions: Acute Exacerbation of Chronic Obstructive Pulmonary Disease | Status: NOT_YET_RECRUITING